학술논문
A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
Document Type
Article
Author
Source
BMC Complementary Medicine & Therapies; 11/22/2023, Vol. 23 Issue 1, p1-23, 23p
Subject
Language
ISSN
26627671
Abstract
Copyright of BMC Complementary Medicine & Therapies is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)